419 related articles for article (PubMed ID: 32311324)
21. Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.
Koc G; Odabasi Z; Tan E
J Clin Neuromuscul Dis; 2020 Sep; 22(1):60-62. PubMed ID: 32833728
[No Abstract] [Full Text] [Related]
22. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.
Tarek M; Savarino A
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):715-723. PubMed ID: 32780273
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
24. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
Lebin JA; LeSaint KT
West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
[TBL] [Abstract][Full Text] [Related]
25. US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
Shehab N; Lovegrove M; Budnitz DS
JAMA Intern Med; 2020 Oct; 180(10):1384-1386. PubMed ID: 32628242
[TBL] [Abstract][Full Text] [Related]
26. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
Mvumbi DM
Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
[No Abstract] [Full Text] [Related]
27. Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
Tilangi P; Desai D; Khan A; Soneja M
Lancet Infect Dis; 2020 Oct; 20(10):1119-1120. PubMed ID: 32450054
[No Abstract] [Full Text] [Related]
28. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
Piszczatoski CR; Powell J
Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
[TBL] [Abstract][Full Text] [Related]
29. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
30. Emerging prophylaxis strategies against COVID-19.
Agrawal S; Goel AD; Gupta N
Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231348
[TBL] [Abstract][Full Text] [Related]
31. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
32. Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India.
Singh AK; Misra A
Diabetes Metab Syndr; 2020; 14(4):497. PubMed ID: 32388327
[No Abstract] [Full Text] [Related]
33. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
Mehta B; Moezinia CJ; Jannat-Khah D; Gibofsky A; Tornberg H; Pearce-Fisher D; Goodman SM; Salmon JE; Ibrahim S
J Clin Rheumatol; 2020 Sep; 26(6):224-228. PubMed ID: 32694358
[TBL] [Abstract][Full Text] [Related]
34. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
Sargin G; Yavaşoğlu Sİ; Yavasoglu I
Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
[No Abstract] [Full Text] [Related]
35. Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.
Pati S; Houston T
Epilepsy Res; 2020 Sep; 165():106399. PubMed ID: 32559589
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
[TBL] [Abstract][Full Text] [Related]
37. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
Ann Intern Med; 2020 Aug; 173(4):287-296. PubMed ID: 32459529
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.
Singh AK; Singh A; Shaikh A; Singh R; Misra A
Diabetes Metab Syndr; 2020; 14(3):241-246. PubMed ID: 32247211
[TBL] [Abstract][Full Text] [Related]
39. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
40. Insights from nanomedicine into chloroquine efficacy against COVID-19.
Hu TY; Frieman M; Wolfram J
Nat Nanotechnol; 2020 Apr; 15(4):247-249. PubMed ID: 32203437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
